Drug Index



Mechanism :

Halofantrine, a phenanthrene methanol, is a blood schizonticide that is active against all malaria parasites. It is active against P. falciparum infections that are resistant to chloroquine and to sulfa drug-pyrimethamine combinations.

Indication :

• Malaria, especially as a part of artemisinin combination therapy (ACT).

Contraindications :

The use of halofantrine is contraindicated in persons with a history of allergy to the drug, with pre-existing cardiac disease, with a family history of sudden death or of congenital prolongation of the QTc interval, who are using other drugs or have a clinical condition known to prolong the QTc interval, who have received treatment with mefloquine in the previous 3 weeks, pregnant women, breastfeeding mothers and children under one year.

Dosing :

Not recommended in children of <10 kg as data is insufficient.

>10 kg: 8 mg/kg/day PO in 3 divided doses every six hours.

Adverse Effect :

Diarrhea, abdominal pain, vomiting, headache, pruritus, elevated liver enzymes, rash, myalgia, back pain, rigors, QT prolongation.

Interaction :

Not known.

Hepatic Dose :

There are no dosage adjustments provided in the manufacturer's labeling; however, half-life may be prolonged and plasma levels may be higher in patients with hepatic impairment; use with caution.
04/07/2020 00:46:16 Halofantrine
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0